Original Research

Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction

Nawroth F, Tandler-Schneider A, Bilger W

Drug, Healthcare and Patient Safety 2015, 7:63-68

Published Date: 15 April 2015